Z 1046

Drug Profile

Z 1046

Latest Information Update: 20 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Zambon Group SpA
  • Class Anti-ischaemics; Antihypertensives; Heart failure therapies; Peripheral vasodilators
  • Mechanism of Action Dopamine D1 receptor agonists; Dopamine D2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Heart failure; Hypertension; Ischaemic heart disorders

Most Recent Events

  • 08 Oct 2001 No-Development-Reported for Congestive heart failure in Europe (Unknown route)
  • 08 Oct 2001 No-Development-Reported for Hypertension in Europe (Unknown route)
  • 08 Oct 2001 No-Development-Reported for Ischaemic heart disorders in Europe (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top